Cell Dissociation Market Report 2026

The cell dissociation market size has grown rapidly in recent years. It will grow from $0.43 billion in 2025 to $0.48 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to expansion of cell-based research activities, increasing use of flow cytometry techniques, growth in academic life sciences research, wider adoption of in vitro cell culture models, availability of commercial dissociation reagents.

The cell dissociation market size is expected to see rapid growth in the next few years. It will grow to $0.78 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing adoption of single-cell genomics, rising investments in cell therapy research, growing demand for reproducible cell processing workflows, expansion of precision medicine studies, increasing use of automated laboratory systems. Major trends in the forecast period include increasing adoption of standardized enzymatic dissociation protocols, rising demand for gentle cell separation techniques, growing use of automated tissue dissociation systems, expansion of single-cell analysis workflows, enhanced focus on cell viability preservation.

The rising incidence of chronic diseases is expected to drive the growth of the cell dissociation market in the coming years. Factors such as aging populations, lifestyle changes, and increasing rates of obesity, physical inactivity, and unhealthy diets contribute to the long-term development of conditions like diabetes, heart disease, and cancer. Cell dissociation plays a critical role in studying chronic diseases by allowing researchers to isolate and analyze individual cells, facilitating the understanding of disease mechanisms and the development of targeted therapies. For example, in April 2025, the Centers for Disease Control and Prevention (CDC), a U.S.-based federal health agency, reported that in 2023 approximately 194 million U.S. adults (76.4%) had one or more chronic conditions, and about 130 million adults (51.4%) had multiple chronic conditions. Thus, the growing prevalence of chronic diseases is propelling the cell dissociation market.

Key companies in the cell dissociation market are focusing on technologically advanced products, such as cell depletion and enrichment kits, to strengthen their competitive position. These kits are designed to selectively deplete or enrich specific cell populations, enhancing the efficiency and accuracy of downstream research and clinical applications. For instance, in February 2023, LevitasBio, a US-based biotechnology company, launched the LeviSelect Suite of Cell Depletion & Enrichment Kits. These kits offer high-speed processing with minimal impact on cell viability, making them ideal for sensitive research environments. Additionally, the LeviSelect kits provide customizable protocols, enabling researchers to precisely target a wide range of cell types.

In March 2023, Agilent Technologies, a US-based company, acquired e-MSion for an undisclosed sum. This acquisition is intended to enhance Agilent’s biopharmaceutical development capabilities by integrating advanced analytical solutions into its portfolio. e-MSion, a US-based early-stage company, specializes in innovative electron capture dissociation (ECD) technology.

Major companies operating in the cell dissociation market are Roche Holding AG, Danaher Corporation, Fujifilm Holdings Corporation, Becton Dickinson and Company, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group AG, Bio-Rad Laboratories Inc., Eppendorf AG, Bio-Techne Corporation, Miltenyi Biotec, BioLegend Inc., Cyagen Biosciences Inc., Cell Signaling Technology Inc., HiMedia Laboratories LLC, Gemini Bio-Products, Biological Industries USA Inc., BrainBits LLC, Biocompare Inc., AAT Bioquest Inc.

North America was the largest region in the cell dissociation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell dissociation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell dissociation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the cell dissociation market by increasing costs of imported enzymes, laboratory instruments, plastic consumables, and automated dissociation systems used in research and clinical laboratories. Research institutions and biotechnology companies in North America and Europe are most affected due to reliance on imported reagents and equipment, while Asia-Pacific faces cost pressure on reagent manufacturing and exports. These tariffs are raising procurement costs and extending purchasing cycles. However, they are also encouraging local reagent production, regional manufacturing of laboratory instruments, and supplier diversification to stabilize long-term availability.

The cell dissociation market research report is one of a series of new reports that provides cell dissociation market statistics, including cell dissociation industry global market size, regional shares, competitors with a cell dissociation market share, detailed cell dissociation market segments, market trends and opportunities, and any further data you may need to thrive in the cell dissociation industry. This cell dissociation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cell dissociation is the process of separating cells from tissues or cell cultures into a single-cell suspension. This can be achieved using enzymatic, mechanical, or chemical methods while maintaining cell viability and functionality for downstream applications. It is an essential step in numerous research, diagnostic, and therapeutic procedures. Effective cell dissociation allows for accurate analysis and use of individual cells in studies such as flow cytometry, cell culture, and single-cell sequencing.

The primary product types for cell dissociation include enzymatic dissociation, non-enzymatic dissociation, instruments, and accessories. Enzymatic dissociation employs specific enzymes to break down the extracellular matrix, enabling the separation of cells from tissues for further analysis. Key tissue types include epithelial and connective tissues, and major applications include tissue dissociation and cell detachment. These products are utilized by pharmaceutical and biotechnology companies, research and academic institutions, clinical research organizations (CROs), and other end-users.

The cell dissociation market consists of revenues earned by entities by providing services such as mechanical dissociation, adherent cell dissociation using enzymes, and suspension cell dissociation via gentle centrifugation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell dissociation market also includes sales of cell dissociation buffers, gentle dissociation reagents, and chelating agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.